Study types
- article 5
Condition tags
- endometriosis 3
- dysmenorrhea 1
- die_deep_infiltrating 1
Top journals
Frequent coauthors
- Yizhou Zhang 2
- Dingjie Xu 1
- Jia Chen 1
- Guanghui Zhu 1
- H Ling 1
- Hong Zheng 1
- Guo‐Qing Jiang 1
- Jiawen Ma 1
- Junying Wu 1
- Chunhua Jiang 1
article
2022
Premature ovarian insufficiency (POI) is a common refractory disease in gynecology, and its etiology and pathogenesis are complex. Psychological stress exerts an impact on women's physical and mental health, and in turn affects the ovarian …
article
2022
Ruxolitinib is a safe and effective therapy of myeloproliferative neoplasm-associated (MPN) myelofibrosis. However, often there are dose reductions and/or therapy interruptions because of therapy-related adverse events (AEs), especially ane…
article
2018
The current therapies for endometriosis are restricted by various side effects and treatment outcome has been less than satisfactory. Shaofu Zhuyu Decoction (SZD), a classic traditional Chinese medicinal (TCM) prescription for dysmenorrhea,…
article
2011
OBJECTIVE: To explore diagnostic and therapeutic methods of patients with deep infiltrating endometriosis. METHODS: Clinical data of a case of complicated deep infiltrating endometriosis were analyzed retrospectively. RESULTS: A 39-year-old…
article
2000
OBJECTIVE: To study the possible effect of major histocompatibility complex-class I (MHC-I) antigen on endometrial stromal cells in endometriosis patients. METHODS: The stromal cells of endometrium was separated and cultured in vitro. gamma…